Newsroom

Sorted by: Latest

-

Distribution Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Distribution Solutions Group, Inc. - DSGR

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Distribution Solutions Group, Inc. (NasdaqGS: DSGR) to affiliates of LKCM Headwater Investments, LLC. Under the terms of the proposed transaction, shareholders of Distribution Solutions will receive $35.00 in cash for each share of Distribution Solutions that they own. KSF is seeking to determine wh...
-

Granite REIT Declares Distribution for November 2026

TORONTO--(BUSINESS WIRE)--Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN) announced today that its board of trustees has declared a distribution of CDN $0.2958 per unit for the month of November 2026. As a result of Granite's previously announced three-for-one unit split, which is expected to be implemented at the close of business on November 23, 2026, each pre-split unit distribution of CDN $0.2958 will be adjusted to CDN $0.0986 per unit on a post-split basis. The split-adjust...
-

Nelkarmi (neladalkib) approved in the US for previously-treated advanced ALK-positive non-small cell lung cancer

PHILADELPHIA--(BUSINESS WIRE)--Nelkarmi (neladalkib) approved in the US for previously-treated advanced ALK-positive non-small cell lung cancer...
-

Octant Appoints Eddy Anglade, M.D., as Chief Medical Officer

EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a clinical-stage drug discovery company developing corrector therapies for protein misfolding diseases, today announced the appointment of Eddy Anglade, M.D., as its first Chief Medical Officer. Dr. Anglade will lead Octant’s clinical development strategy, including advancing its lead program, OCT-980 for rhodopsin-associated autosomal dominant retinitis pigmentosa (RHO-adRP). “OCT-980 is the first molecule from our platform to reach patients,...
-

72% of UK Business Leaders Expect AI Agents to Outnumber Human Agents Within Two Years

LONDON--(BUSINESS WIRE)--Zendesk today released its 2027 Customer Experience (CX) Trends report*, revealing that nearly three-quarters of UK business leaders expect the AI agents they operate to outnumber human agents within two years. Based on insights from thousands of consumers, business leaders and customer service agents globally, the report points to a new phase for CX: the era of AI Management. Today, 79% of UK business leaders consider AI agents part of their workforce and 87% say manag...
-

WaFd Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of WaFd, Inc. - WAFD

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of WaFd, Inc. (NasdaqGS: WAFD) and EverBank Financial Corp. Upon closing of the proposed transaction, WaFd shareholders are expected to own 40.8% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to WaFd shareholder...
-

NEUROPACE, INC. INVESTIGATION: NPCE Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired NeuroPace securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com,...
-

Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Personalis, Inc. (NasdaqGM: PSNL) to Tempus AI, Inc. (NasdaqGS: TEM). Under the terms of the proposed transaction, shareholders of Personalis will receive $16.25 per common share. The consideration is reported to be structured as a 100% stock transaction, with Tempus having the option to elect p...
-

Tessera Brings Linked Billing with Claude Platform to the Enterprise

SAN JOSE, Calif.--(BUSINESS WIRE)--Tessera Labs, the AI platform for end-to-end enterprise systems transformation, today made linked billing with Claude Platform available to its customers, letting them put the Claude API usage their teams generate in Tessera on their own Claude Platform organization.Tessera’s customers include some of the largest companies in the world, and they have already invested in how they buy and govern AI, from existing agreements to spending controls and oversight. Lin...
-

Dana Incorporated Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Dana Incorporated - DAN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Dana Incorporated (NYSE: DAN) and Eaton Corporation plc (NYSE: ETN). Upon completion of the proposed transaction, Dana shareholders will own approximately 49.9% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair t...